Trial · NCT02852967
Adverse events192
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 192
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Viral upper respiratory tract infection | Infections and infestations | Belumosudil 200 mg QD + Placebo | 2 | 23 | |
| other | Viral upper respiratory tract infection | Infections and infestations | Belumosudil 200 mg BID (Twice Daily) + Placebo | 3 | 22 | |
| other | Viral upper respiratory tract infection | Infections and infestations | Belumosudil 400 mg QD + Placebo | 0 | 21 | |
| other | Viral upper respiratory tract infection | Infections and infestations | Belumosudil 600 mg/Day | 1 | 26 | |
| other | Viral upper respiratory tract infection | Infections and infestations | Placebo | 0 | 92 | |
| other | Viral upper respiratory tract infection | Infections and infestations | All Belumosudil | 6 | 92 | |
| other | Influenza | Infections and infestations | Belumosudil 200 mg QD + Placebo | 0 | 23 | |
| other | Influenza | Infections and infestations | Belumosudil 200 mg BID (Twice Daily) + Placebo | 1 | 22 | |
| other | Influenza | Infections and infestations | Belumosudil 400 mg QD + Placebo | 3 | 21 | |
| other | Influenza | Infections and infestations | Belumosudil 600 mg/Day | 0 | 26 | |
| other | Influenza | Infections and infestations | Placebo | 0 | 92 | |
| other | Influenza | Infections and infestations | All Belumosudil | 4 | 92 | |
| other | Upper respiratory tract infection | Infections and infestations | Belumosudil 200 mg QD + Placebo | 1 | 23 | |
| other | Upper respiratory tract infection | Infections and infestations | Belumosudil 200 mg BID (Twice Daily) + Placebo | 0 | 22 | |
| other | Upper respiratory tract infection | Infections and infestations | Belumosudil 400 mg QD + Placebo | 1 | 21 | |
| other | Upper respiratory tract infection | Infections and infestations | Belumosudil 600 mg/Day | 1 | 26 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 1 | 92 | |
| other | Upper respiratory tract infection | Infections and infestations | All Belumosudil | 3 | 92 | |
| other | Urinary tract infection | Infections and infestations | Belumosudil 200 mg QD + Placebo | 0 | 23 | |
| other | Urinary tract infection | Infections and infestations | Belumosudil 200 mg BID (Twice Daily) + Placebo | 0 | 22 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02852967/events